Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 356441 - 356460 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Norway | (H02AB04) methylprednisolone | Solu-Medrol 1 g | , sett, Pulver og væske til injeksjons-/infusjonsvæske, oppløsning, 1 g , sett | Retail price with vat |
$0-0 |
$0-0 |
n/a | PfizerAS |
| Norway | (H02CA03) ketoconazole (adm: O) | Ketoconazole Esteve 200 mg | 60 stk, Blisterpakning, Tablett, 200 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Cushing Syndrome | EstevePharmaceuticalsS.A |
| Norway | (H05AA02) teriparatide (adm: P) | Terrosa 20 mikrog/80 mikroliter | 28 doser, Ferdigfylt penn, Injeksjonsvæske, oppløsning i ferdigfylt penn, 20 mikrog/80 mikroliter , Ferdigfylt penn | Retail price with vat |
$0-0 |
$0-0 |
Osteoporosis | OrifarmAS |
| Norway | (J01CR05) piperacillin and beta-lactamase inhibitor (adm: P, refers to piperacillin) | Piperacillin/Tazobactam Fresenius Kabi 4 g/0,5 g | 10 stk, Hetteglass, Pulver til infusjonsvæske, oppløsning, 4 g/0,5 g , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
n/a | OrifarmAS |
| Norway | (J01DD01) cefotaxime (adm: P) | Cefotaxim Navamedic 1 g | 10 x 1 g, Hetteglass, Pulver til injeksjons-/infusjonsvæske, oppløsning, 1 g , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
n/a | NavamedicASA |
| Norway | (J01DD08) cefixime (adm: O) | Cefixime FrostPharma 20 mg/ml | 60 ml, Flaske av glass, Granulat til mikstur, suspensjon, 20 mg/ml , Flaske av glass | Retail price with vat |
$0-0 |
$0-0 |
n/a | FrostPharmaAB |
| Norway | (J01EE01) sulfamethoxazole and trimethoprim | Bactrim 400 mg/80 mg | 20 stk, Blisterpakning, Tablett, 400 mg/80 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
n/a | OrifarmAS |
| Norway | (J05AR02) lamivudine and abacavir | Abacavir/Lamivudine Viatris 600 mg/300 mg | 30 stk, Blisterpakning, Tablett, filmdrasjert, 600 mg/300 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
n/a | ViatrisLimited |
| Norway | (J07BB02) influenza, inactivated, split virus or surface antigen | Influvac 15 mikrog HA/15 mikrog HA/15 mikrog HA | 10 x 0.5 ml, Ferdigfylt sprøyte, Injeksjonsvæske, suspensjon i ferdigfylt sprøyte, 15 mikrog HA/15 mikrog HA/15 mikrog HA , Ferdigfylt sprøyte | Retail price with vat |
$0-0 |
$0-0 |
n/a | ViatrisAS |
| Norway | (J07BB02) influenza, inactivated, split virus or surface antigen | Influvac 15 mikrog HA/15 mikrog HA/15 mikrog HA | 0.5 ml, Ferdigfylt sprøyte, Injeksjonsvæske, suspensjon i ferdigfylt sprøyte, 15 mikrog HA/15 mikrog HA/15 mikrog HA , Ferdigfylt sprøyte | Retail price with vat |
$0-0 |
$0-0 |
n/a | ViatrisAS |
| Norway | (J07CA02) diphtheria-pertussis-poliomyelitis-tetanus | Boostrix Polio (ikke angitt) | 1 x 0.5 ml, stk, Ferdigfylt sprøyte av glass, Injeksjonsvæske, suspensjon i ferdigfylt sprøyte, (ikke angitt) , Ferdigfylt sprøyte av glass | Retail price with vat |
$0-0 |
$0-0 |
n/a | GlaxoSmithKlineAS |
| Norway | (L01EB04) osimertinib (adm: O) | Tagrisso 40 mg | 30 stk, Blisterpakning, Tablett, filmdrasjert, 40 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaAB(2) |
| Norway | (L01EB04) osimertinib (adm: O) | Tagrisso 80 mg | 30 stk, Blisterpakning, Tablett, filmdrasjert, 80 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaAB(2) |
| Norway | (L01EC03) encorafenib (adm: O) | Braftovi 50 mg | 28 stk, Blisterpakning, Kapsel, hard, 50 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Melanoma;Colorectal Neoplasms | PierreFabreMedicament |
| Norway | (L01EC03) encorafenib (adm: O) | Braftovi 75 mg | 42 stk, Blisterpakning, Kapsel, hard, 75 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Melanoma;Colorectal Neoplasms | PierreFabreMedicament |
| Norway | (L01EF01) palbociclib (adm: O) | Ibrance 100 mg | 21 stk, Blisterpakning, Kapsel, hard, 100 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | OrifarmAS |
| Norway | (L01EF01) palbociclib (adm: O) | Ibrance 100 mg | 21 stk, Blisterpakning, Kapsel, hard, 100 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerEuropeMAEEIG(1) |
| Norway | (L01EF01) palbociclib (adm: O) | Ibrance 125 mg | 21 stk, Blisterpakning, Kapsel, hard, 125 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerEuropeMAEEIG(1) |
| Norway | (L01EF01) palbociclib (adm: O) | Ibrance 125 mg | 21 stk, Blisterpakning, Kapsel, hard, 125 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | OrifarmAS |
| Norway | (L01EF01) palbociclib (adm: O) | Ibrance 75 mg | 21 stk, Blisterpakning, Kapsel, hard, 75 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerEuropeMAEEIG(1) |
Pages
